E-LIB Suche - Ergebnisse für: Lenz, G.

1

Pola‐R‐CHP versus R‐CHOEP in young patients with high‐risk ..:

Lenz, G. ; Tilly, H. ; Ziepert, M....
Hematological Oncology. 41 (2023) S2 - p. 420-421 , 2023

Link: https://doi.org/10.1002/..

2

PHASE 3 TRIAL OF SUBCUTANEOUS EPCORITAMAB + R‐CHOP VERSUS R..:

Sehn, L. H ; Chamuleau, M. ; Lenz, G....
Hematological Oncology. 41 (2023) S2 - p. 849-850 , 2023

Link: https://doi.org/10.1002/..

3

IMMUNE CONTEXTURE ANALYSIS IN POLARIX SUGGESTS RESPONSE TO ..:

Morschhauser, F. ; Hatzi, K. ; Lenz, G....
Hematological Oncology. 41 (2023) S2 - p. 223-225 , 2023

Link: https://doi.org/10.1002/..

4

CONSOLIDATIVE HCT‐ASCT IS SUPERIOR TO NON‐MYELOABLATIVE CHE..:

Illerhaus, G. ; Ferreri, A. ; Binder, M....
Hematological Oncology. 41 (2023) S2 - p. 41-43 , 2023

Link: https://doi.org/10.1002/..

5

CIRCULATING TUMOR DNA (CTDNA) STATUS AND CLINICAL OUTCOMES ..:

Herrera, A. F. ; Tracy, S. ; Sehn, L. H....
Hematological Oncology. 41 (2023) S2 - p. 175-177 , 2023

Link: https://doi.org/10.1002/..

6

Final safety and efficacy results of copanlisib monotherapy..:

Dreyling, M. ; Santoro, A. ; Mollica, L....
Hematological Oncology. 41 (2023) S2 - p. 560-562 , 2023

Link: https://doi.org/10.1002/..

7

HIGH RATE OF METABOLIC COMPLETE RESPONSE AFTER LOW DOSE RAD..:

Herfarth, K. ; Scholz, C. W. ; Hübel, K....
Hematological Oncology. 41 (2023) S2 - p. 218-220 , 2023

Link: https://doi.org/10.1002/..

8

Radiotherapy in Young, High-Risk Patients with Aggressive B..:

Oertel, M. ; Ziepert, M. ; Nacke, N....
International Journal of Radiation Oncology*Biology*Physics. 117 (2023) 2 - p. S63 , 2023

Link: https://doi.org/10.1016/..

9

Allogeneic transplantation in T‐cell lymphoma: Lessons from..:

Tournilhac, O. ; Altmann, B. ; Friedrichs, B....
Hematological Oncology. 41 (2023) S2 - p. 512-513 , 2023

Link: https://doi.org/10.1002/..

10

P478: THE GERMLINE VARIANT GFI1-36N PROMOTES GENETIC INSTAB..:

Vorwerk, J. ; Frank, D. ; Sun, K....
HemaSphere. 6 (2022) - p. 377-378 , 2022

Link: https://doi.org/10.1097/..

11

Correction to: The current standing of autologous haematopo..:

Willison, A. G. ; Ruck, T. ; Lenz, G...
Journal of Neurology. 269 (2022) 7 - p. 3959-3961 , 2022

Link: https://doi.org/10.1007/..

12

PB2113: FRONTMIND: A PHASE III, RANDOMIZED, DOUBLE-BLIND ST..:

Vitolo, U. ; Nowakowski, G. S. ; Burke, J. M....
HemaSphere. 6 (2022) - p. 1984-1985 , 2022

Link: https://doi.org/10.1097/..

13

P1190: OUTCOMES BY BCL2 AND MYC EXPRESSION AND REARRANGEMEN..:

Morschhauser, F. ; Jiang, Y. ; Jardin, F....
HemaSphere. 6 (2022) - p. 1076-1077 , 2022

Link: https://doi.org/10.1097/..

14

The current standing of autologous haematopoietic stem cell..:

Willison, A. G. ; Ruck, T. ; Lenz, G...
Journal of Neurology. 269 (2022) 7 - p. 3937-3958 , 2022

Link: https://doi.org/10.1007/..

15

Recent developments in drug delivery strategies for targeti..:

Morás, A.M. ; Henn, J.G. ; Steffens Reinhardt, L...
Life Sciences. 287 (2021) - p. 120128 , 2021

Link: https://doi.org/10.1016/..